Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M: Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol. 1997, 42 (4): 604-612. 10.1002/ana.410420411.
Article
CAS
PubMed
Google Scholar
Vassos E, Panas M, Kladi A, Vassilopoulos D: Higher levels of extroverted hostility detected in gene carriers at risk for Huntington's disease. Biol Psychiatry. 2007, 62 (12): 1347-1352. 10.1016/j.biopsych.2006.12.016.
Article
PubMed
Google Scholar
Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, Marder K, Penchaszadeh G, Roberts SA, Gayan J, et al: Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA. 2004, 101 (10): 3498-3503.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yoon G, Kramer J, Zanko A, Guzijan M, Lin S, Foster-Barber A, Boxer AL: Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology. 2006, 67 (7): 1265-1267. 10.1212/01.wnl.0000238390.86304.4e.
Article
CAS
PubMed
Google Scholar
Zizak VS, Filoteo JV, Possin KL, Lucas JA, Rilling LM, Davis JD, Peavy G, Wong A, Salmon DP: The ubiquity of memory retrieval deficits in patients with frontal-striatal dysfunction. Cogn Behav Neurol. 2005, 18 (4): 198-205. 10.1097/01.wnn.0000192134.53616.39.
Article
PubMed
Google Scholar
Berrios GE, Wagle AC, Markova IS, Wagle SA, Ho LW, Rubinsztein DC, Whittaker J, Ffrench-Constant C, Kershaw A, Rosser A, et al: Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers. Psychiatry Res. 2001, 102 (3): 217-225. 10.1016/S0165-1781(01)00257-8.
Article
CAS
PubMed
Google Scholar
Myers RH, Madden JJ, Teague JL, Falek A: Factors related to onset age of Huntington disease. Am J Hum Genet. 1982, 34 (3): 481-488.
PubMed Central
CAS
PubMed
Google Scholar
Roos RA, Hermans J, Vegter-Van Der Vlis M, Van Ommen GJ, Bruyn GW: Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry. 1993, 56 (1): 98-100. 10.1136/jnnp.56.1.98.
Article
PubMed Central
CAS
PubMed
Google Scholar
Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, et al: Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci USA. 2005, 102 (31): 11023-11028. 10.1073/pnas.0504921102.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cha JH: Transcriptional signatures in Huntington's disease. Prog Neurobiol. 2007, 83 (4): 228-248. 10.1016/j.pneurobio.2007.03.004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D, et al: Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet. 2006, 15 (6): 965-977. 10.1093/hmg/ddl013.
Article
CAS
PubMed
Google Scholar
Sipione S, Rigamonti D, Valenza M, Zuccato C, Conti L, Pritchard J, Kooperberg C, Olson JM, Cattaneo E: Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet. 2002, 11 (17): 1953-1965. 10.1093/hmg/11.17.1953.
Article
CAS
PubMed
Google Scholar
Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, Regulier E, Delorenzi M, Tabrizi SJ, Luthi-Carter R: Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci USA. 2007, 104 (36): 14424-14429. 10.1073/pnas.0703652104.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, et al: Towards a transgenic model of Huntington's disease in a non-human primate. Nature. 2008, 453 (7197): 921-924. 10.1038/nature06975.
Article
PubMed Central
CAS
PubMed
Google Scholar
Crook ZR, Housman D: Huntington's disease: can mice lead the way to treatment?. Neuron. 2011, 69 (3): 423-435. 10.1016/j.neuron.2010.12.035.
Article
CAS
PubMed
Google Scholar
Johnson CD, Davidson BL: Huntington's disease: progress toward effective disease-modifying treatments and a cure. Hum Mol Genet. 2010, 19 (R1): R98-R102. 10.1093/hmg/ddq148.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ross CA: Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron. 2002, 35 (5): 819-822. 10.1016/S0896-6273(02)00872-3.
Article
CAS
PubMed
Google Scholar
Ross CA, Tabrizi SJ: Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011, 10 (1): 83-98. 10.1016/S1474-4422(10)70245-3.
Article
CAS
PubMed
Google Scholar
Kennedy L, Shelbourne PF: Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?. Hum Mol Genet. 2000, 9 (17): 2539-2544. 10.1093/hmg/9.17.2539.
Article
CAS
PubMed
Google Scholar
Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP: Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat Genet. 1997, 15 (2): 197-200. 10.1038/ng0297-197.
Article
CAS
PubMed
Google Scholar
Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, Steffan JS, Thompson LM, Wetzel R, Yang XW: Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron. 2009, 64 (6): 828-840. 10.1016/j.neuron.2009.11.020.
Article
PubMed Central
CAS
PubMed
Google Scholar
Shehadeh J, Fernandes HB, Zeron Mullins MM, Graham RK, Leavitt BR, Hayden MR, Raymond LA: Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol Dis. 2006, 21 (2): 392-403. 10.1016/j.nbd.2005.08.001.
Article
CAS
PubMed
Google Scholar
Group HS: Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord. 1996, 11 (2): 136-142.
Article
Google Scholar
Ferreira IL, Cunha-Oliveira T, Nascimento MV, Ribeiro M, Proenca MT, Januario C, Oliveira CR, Rego AC: Bioenergetic dysfunction in Huntington's disease human cybrids. Exp Neurol. 2011, 231 (1): 127-134. 10.1016/j.expneurol.2011.05.024.
Article
CAS
PubMed
Google Scholar
Josefsen K, Nielsen SM, Campos A, Seifert T, Hasholt L, Nielsen JE, Norremolle A, Skotte NH, Secher NH, Quistorff B: Reduced gluconeogenesis and lactate clearance in Huntington's disease. Neurobiol Dis. 2010, 40 (3): 656-662. 10.1016/j.nbd.2010.08.009.
Article
CAS
PubMed
Google Scholar
Tasset I, Sanchez-Lopez F, Aguera E, Fernandez-Bolanos R, Sanchez FM, Cruz-Guerrero A, Gascon-Luna F, Tunez I: NGF and nitrosative stress in patients with Huntington's disease. J Neurol Sci. 2012, 315 (1–2): 133-136.
Article
CAS
PubMed
Google Scholar
Van Roon-Mom WM, Pepers BA, Hoen PA T, Verwijmeren CA, Den Dunnen JT, Dorsman JC, Van Ommen GB: Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease. BMC Mol Biol. 2008, 9: 84-10.1186/1471-2199-9-84.
Article
PubMed Central
PubMed
Google Scholar
Weir DW, Sturrock A, Leavitt BR: Development of biomarkers for Huntington's disease. Lancet Neurol. 2011, 10 (6): 573-590. 10.1016/S1474-4422(11)70070-9.
Article
CAS
PubMed
Google Scholar
Chan AW, Kocerha J: The path to microRNA therapeutics in psychiatric and neurodegenerative disorders. Front Genet. 2012, 3: 82.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ: Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet. 2010, 19 (20): 3919-3935. 10.1093/hmg/ddq306.
Article
PubMed Central
CAS
PubMed
Google Scholar
Liang Y, Jansen M, Aronow B, Geiger H, Van Zant G: The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice. Nat Genet. 2007, 39 (2): 178-188. 10.1038/ng1938.
Article
CAS
PubMed
Google Scholar
Mitsunaga K, Kikuchi J, Wada T, Furukawa Y: Latexin regulates the abundance of multiple cellular proteins in hematopoietic stem cells. J Cell Physiol. 2012, 227 (3): 1138-1147. 10.1002/jcp.22834.
Article
CAS
PubMed
Google Scholar
Muthusamy V, Premi S, Soper C, Platt J, Bosenberg M: The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma. J Invest Dermatol. 2013, 133 (7): 1827-1833. 10.1038/jid.2013.48.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, et al: A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J Exp Med. 2008, 205 (8): 1869-1877. 10.1084/jem.20080178.
Article
PubMed Central
PubMed
Google Scholar
Kwan W, Trager U, Davalos D, Chou A, Bouchard J, Andre R, Miller A, Weiss A, Giorgini F, Cheah C, et al: Mutant huntingtin impairs immune cell migration in Huntington disease. J Clin Invest. 2012, 122 (12): 4737-4747. 10.1172/JCI64484.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sanchez-Lopez F, Tasset I, Aguera E, Feijoo M, Fernandez-Bolanos R, Sanchez FM, Ruiz MC, Cruz AH, Gascon F, Tunez I: Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease. Neurol Res. 2012, 34 (7): 721-724. 10.1179/1743132812Y.0000000073.
Article
CAS
PubMed
Google Scholar
Dupont P, Besson MT, Devaux J, Lievens JC: Reducing canonical Wingless/Wnt signaling pathway confers protection against mutant Huntingtin toxicity in Drosophila. Neurobiol Dis. 2012, 47 (2): 237-247. 10.1016/j.nbd.2012.04.007.
Article
CAS
PubMed
Google Scholar
Kalathur RK, Hernandez-Prieto MA, Futschik ME: Huntington's disease and its therapeutic target genes: a global functional profile based on the HD research crossroads database. BMC Neurol. 2012, 12: 47-10.1186/1471-2377-12-47.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, et al: Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiol Dis. 2013, 52: 84-93.
Article
PubMed Central
CAS
PubMed
Google Scholar
Silva AC, Almeida S, Laco M, Duarte AI, Domingues J, Oliveira CR, Januario C, Rego AC: Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers. Mitochondrion. 2013, S1567-7249 (13): 00080-00089.
Google Scholar
Putkhao K, Kocerha J, Cho IK, Yang J, Parnpai R, Chan AW: Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's Disease. Stem Cells Dev. 2013, 22 (8): 1198-1205. 10.1089/scd.2012.0469.
Article
PubMed Central
CAS
PubMed
Google Scholar